Silencing of CD133 inhibits GLUT1‐mediated glucose transport through downregulation of the HER3/Akt/mTOR pathway in colon cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Silencing of CD133 inhibits GLUT1‐mediated glucose transport through downregulation of the HER3/Akt/mTOR pathway in colon cancer

Published:2020-03 Issue:6 Volume:594 Page:1021-1035
ISSN:0014-5793
Container-title:FEBS Letters
language:en
Short-container-title:FEBS Lett

Author:

Kim Hyungjoo¹^ORCID,Ju Ji‐Hyun¹,Son Seogho¹,Shin Incheol¹²^ORCID

Affiliation:

1. Department of Life Science Hanyang University Seoul Korea

2. Natural Science Institute Hanyang University Seoul Korea

Publisher

Wiley

Subject

Cell Biology,Genetics,Molecular Biology,Biochemistry,Structural Biology,Biophysics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/1873-3468.13686

Reference56 articles.

1. AC133, a Novel Marker for Human Hematopoietic Stem and Progenitor Cells

2. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity

3. Characterization of a subpopulation of colon cancer cells with stem cell-like properties

4. Identification of human brain tumour initiating cells

5. The Role of CD133 in Normal Human Prostate Stem Cells and Malignant Cancer-Initiating Cells

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional Roles of CD133: More than Stemness Associated Factor Regulated by the Microenvironment;Stem Cell Reviews and Reports;2023-11-03

2. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2;Phytomedicine;2023-06

3. How is the AKT/mTOR pathway involved in cell migration and invasion?;BIOCELL;2023

4. Tubulin Isotypes: Emerging Roles in Defining Cancer Stem Cell Niche;Frontiers in Immunology;2022-05-26

5. Circular RNA circDENND4C facilitates proliferation, migration and glycolysis of colorectal cancer cells through miR-760/GLUT1 axis;EUR REV MED PHARMACO;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3